Page last updated: 2024-08-24

aromasil and bosutinib

aromasil has been researched along with bosutinib in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bardy-Bouxin, N; Bellet, M; Chow, L; Duvillié, L; Goss, P; Láng, I; Lebrun, F; Leip, E; Moy, B; Neven, P; Sarosiek, T; Turnbull, K; Xu, B; Zacharchuk, C	1

Trials

1 trial(s) available for aromasil and bosutinib

Article	Year
Bosutinib in combination with the aromatase inhibitor exemestane: a phase II trial in postmenopausal women with previously treated locally advanced or metastatic hormone receptor-positive/HER2-negative breast cancer. The oncologist, 2014, Volume: 19, Issue:4 Topics: Androstadienes; Aniline Compounds; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Aromatase Inhibitors; Breast Neoplasms; Disease-Free Survival; Female; Humans; Nitriles; Postmenopause; Protein Kinase Inhibitors; Quinolines; Receptor, ErbB-2; Receptors, Estrogen; Receptors, Progesterone	2014

Article

Year

Bosutinib in combination with the aromatase inhibitor exemestane: a phase II trial in postmenopausal women with previously treated locally advanced or metastatic hormone receptor-positive/HER2-negative breast cancer.

The oncologist, 2014, Volume: 19, Issue:4

Topics: Androstadienes; Aniline Compounds; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Aromatase Inhibitors; Breast Neoplasms; Disease-Free Survival; Female; Humans; Nitriles; Postmenopause; Protein Kinase Inhibitors; Quinolines; Receptor, ErbB-2; Receptors, Estrogen; Receptors, Progesterone

2014